Advanced Search

Journal of Traditional Chinese Medicine >

2025 , Vol. 45 >Issue 4: 829 - 835

DOI: https://doi.org/10.19852/j.cnki.jtcm.20241226.001

Original Articles

Efficacy and safety of Tuomin Zhiti decoction (脱敏止嚏汤) on patients with seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial

  • Weibo ZHAO ,
  • Yaqi WANG ,
  • Lingyao KONG ,
  • Tianyi WANG ,
  • Haihong ZHAO ,
  • Ying ZHANG ,
  • Bin LUO ,
  • Ji WANG ,
  • Qi WANG
Expand
  • 1 National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
    2 College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China
    3 Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
    4 Beijing University of Chinese Medicine International School, Beijing 100029, China
WANG Qi, National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. wangqi710@126.com，Telephone: +86-17801016686
WANG Ji, National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. doctorwang2009@126.com;

Received date: 2024-08-22

  Accepted date: 2024-12-12

  Online published: 2024-12-26

Supported by

Fundamental Research Funds for the Central Universities(2023-JYB-JBZD-009);High level Key Discipline of National Administration of Traditional Chinese Medicine-Traditional Chinese Constitutional Medicine(zyyzdxk-2023251);General program of National Natural Science Foundation of China: Study on the Mechanism of "the Simultaneous Prevention of Different Diseases" of Allergic Constitution Regulating Formula based on DNA Trap Mediated Eosinophil-Derived Dendritic Cells Cell Crosstalk(82174243);General Project of Beijing Natural Science Foundation: Study on the Mechanism of Guominkang for Treating Allergic Rhinitis through Regulating Body Constitution based on Vacuolating Cytotoxin A-mediated Eosinophil-derived Dendritic Cell Cell immune microenvironment(7242227)

Fold

Abstract

OBJECTIVE: To evaluate the clinical efficacy and safety of Tuomin Zhiti decoction (脱敏止嚏汤, TZD) in the short-term treatment of seasonal allergic rhinitis (SAR).

METHODS: This study is a randomized, double-blind placebo-controlled, and single-center clinical trial. In April 2021, during the spring pollen season in Beijing, 94 SAR patients aged 19-60 years were randomized (1:1 ratio) to receive two weeks of TZD or placebo. The primary outcomes were the change of Total Nasal Symptom Score (TNSS) and Total Ocular Symptom Score (TOSS) from baseline to the end of treatment. Secondary outcomes were the changed score of the mini Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), Rescue Medication Score (RMS), and Patient Global Impression of Change (PGIC). All adverse events were recorded and evaluated by two senior physicians.

RESULTS: TZD significantly reduced both the total nasal symptom scores and total ocular symptom scores compared to scores at baseline, while the placebo group showed an increasing trajectory in both symptom scores. Compared to the placebo group, the TZD group also showed a greater improvement in the quality of life, scores of RMS, nasal and eye symptoms scores after TZD treatment (P < 0.001). Most notably, at the end of treatment, the proportion of remission measured by PGIC was significantly higher in the TZD group (82.97%) compared with the placebo group (47.72%, P < 0.001).

CONCLUSION: This study suggested that two weeks of TZD is an effective and safe treatment for SAR patients and spring pollen allergy, TZD could significantly improve the nasal and eye symptoms and improve the quality of life of patients.

Key words： rhinitis, allergic, seasonal; quality of life; Tuomin Zhiti decoction; randomized controlled trial

Cite this article

Weibo ZHAO , Yaqi WANG , Lingyao KONG , Tianyi WANG , Haihong ZHAO , Ying ZHANG , Bin LUO , Ji WANG , Qi WANG . Efficacy and safety of Tuomin Zhiti decoction (脱敏止嚏汤) on patients with seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial[J]. Journal of Traditional Chinese Medicine, 2025 , 45(4) : 829 -835 . DOI: 10.19852/j.cnki.jtcm.20241226.001

References

1. Rondón C, Fernandez J, Canto G, Blanca M. Local allergic rhinitis: concept, clinical manifestations, and diagnostic approach. J Investig Allergol Clin Immunol 2010; 20: 364-71; quiz 2 p following 371.
2. Bro?ek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol 2017; 140: 950-8.
3. Tang R, Lei S, Zhu L, Lyu Y, Li H. Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study. Front Immunol 2022; 13: 913424.
4. Bousquet J, Schünemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol 2020; 145: 70-80.e3.
5. Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 1997; 99: S773-80.
6. Chan RY, Chien WT. The effects of two Chinese herbal medicinal formulae vs placebo controls for treatment of allergic rhinitis: a randomised controlled trial. Trials 2014; 15: 261.
7. Zhao J, Yan X, Gai J, et al. Efficacy of Bimin decoction for patients with perennial allergic rhinitis: an open-label non-inferiority randomized controlled trial. Trials 2019; 20: 802.
8. Yang SH, Yu CL, Chen YL, Chiao SL, Chen ML. Traditional Chinese Medicine, Xinyi San, reduces nasal symptoms of patients with perennial allergic rhinitis by its diverse immunomodulatory effects. Int Immunopharmacol 2010; 10: 951-8.
9. Luo Q, Zhang CS, Yang L, et al. Potential effectiveness of Chinese herbal medicine Yuping Feng san for adult allergic rhinitis: a systematic review and Meta-analysis of randomized controlled trials. BMC Complement Altern Med 2017; 17: 485.
10. Cheng L, Chen J, Fu Q, et al. Chinese society of allergy guidelines for diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res 2018; 10: 300- 53.
11. Cheng J, Zhang M, Zheng Y, Wang J, Wang Q. Integrative analysis of network pharmacology and proteomics to identify key targets of Tuomin-Zhiti-decoction for allergic rhinitis. J Ethnopharmacol 2022; 296: 115448.
12. Yung TY, Zhang H, Tang LC, et al. Acupuncture and herbal moxibustion for the treatment of 'BiQiu' (allergic rhinitis symptoms) in a Hong Kong Chinese medicine clinic: a randomized controlled trial. Chin Med 2019; 14: 50.
13. Pfaar O, Demoly P, Gerth van Wijk R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy 2014; 69: 854-67.
14. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin Exp Allergy 2000; 30: 132-40.
15. Zhang Y, Xi L, Gao Y, et al. Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis. Clin Transl Allergy 2022; 12: e12094.
16. Okubo K, Suzuki T, Tanaka A, Aoki H. Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial. J Drug Assess 2019; 8: 104-14.
17. Jung JW, Kang HR, Ji GE, et al. Therapeutic effects of fermented red ginseng in allergic rhinitis: a randomized, double-blind, placebo-controlled study. Allergy Asthma Immunol Res 2011; 3: 103-10.
18. M?sges R, Bachert C, Panzner P, et al. Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: a randomized, multicenter, double-blind, placebo-controlled trial. Allergy 2018; 73: 1842-50.
19. Welch MJ, Meltzer EO, Simons FE. H1-antihistamines and the central nervous system. Clin Allergy Immunol 2002; 17: 337-88.
20. Wang J, Wang T, Li YS, Li LR, Zheng YF, Wang Q. Allergic constitution theory of Chinese medicine and its assessment criterion and related studies. Chin J Integr Med 2015; 21: 716-20.
21. Zhao Y, Woo KS, Ma KH, et al. Treatment of perennial allergic rhinitis using Shi-Bi-Lin, a Chinese herbal formula. J Ethnopharmacol 2009; 122: 100-5.
22. Zhang Y, Chen Z, Chen L, et al. Astragali Radix (Huangqi): a time-honored nourishing herbal medicine. Chin Med 2024; 19: 119.
23. Li Y, Fu CM, Ren B, et al. Study on attenuate and synergistic mechanism between aconiti lateralis praeparata radix and glycyrrhizae radix for toxicity reduction based on metabonomic of MI-RI mouse cardiomyocytes. Zhong Guo Zhong Yao Za Zhi 2014; 39: 3166-71.
Options
Outlines

/

〈 〉